dMed

company

About

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$100M
Industries
Biopharma,Medical,Pharmaceutical
Founded date
Aug 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions.

dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$208M
dMed has raised a total of $208M in funding over 2 rounds. Their latest funding was raised on Jul 10, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 10, 2021 Series C $50M 1 Detail
Dec 17, 2020 Series C $100M 2 Detail
Oct 16, 2019 Series B $50M 1 Detail
Dec 1, 2016 Series A $8M 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
dMed is funded by 4 investors. Superstring Capital and Kaiser Permanente are the most recent investors.
Investor Name Lead Investor Funding Round
Superstring Capital Series C
Kaiser Permanente Series C
Lilly Asia Ventures Series C
Tairui Investment Series A